Fig. 2.
Fold changes and predictor importance estimates of HBV RNA, HBV DNA, HBsAg, and HBeAg. a Fold changes of HBV biomarkers in the SR (red lines) and non-SR patients (blue lines). b Fold changes of HBV biomarkers in HL and non-HL patients. c Comparisons of 12-week fold changes in five patient groups. Radar charts revealed predictor importance estimates of HBV biomarkers in the prediction of HBeAg seroconversion (d) or HBsAg loss (e). High values of predictor importance estimates indicate the significance of predictors